dc.contributor.author | Mavrotas, Myrto | |
dc.contributor.author | Murray, Brian | |
dc.date.accessioned | 2020-07-15T07:19:46Z | |
dc.date.available | 2020-07-15T07:19:46Z | |
dc.date.issued | 2020-02 | |
dc.identifier.citation | Myrto Mavrotas and Brian Murray. Mania as a possible complication of immunotherapy. Progress in Neurology and Psychiatry, Vol. 24 Iss. 1 2020 | en |
dc.identifier.issn | 1931-227X | |
dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/506 | |
dc.description | Freely available online. | en |
dc.description.abstract | Immunotherapy is still a relatively new cancer therapy and this article serves as a reminder to psychiatric teams to consider immunotherapy as a possible factor in psychiatric presentations. Here, the authors present the case of a woman who developed signs of personality changes and acute mania after treatment with checkpoint inhibitors ipilimumab and nivolumab | en |
dc.description.uri | https://doi.org/10.1002/pnp.555 | en |
dc.language.iso | en | en |
dc.subject | Mania | en |
dc.subject | Immunotherapy | en |
dc.subject | Cancer | en |
dc.title | Mania as a possible complication of immunotherapy | en |
dc.type | Article | en |